nach oben

Urolithiasis

Erschienen in:

01.08.2005 | Invited Review

Bone mineral content in calcium renal stone formers

verfasst von: A. Trinchieri

Erschienen in: Urolithiasis | Ausgabe 4/2005

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic renal calcium stone disease often presents with reduced bone mineral content. Investigations using non-invasive methods for the measurement of bone mineral content (single and dual-photon absorptiometry, dual-energy x-ray absorptiometry, quantitative computed tomodensitometry) show a slight decrease in skeletal mineral content of idiopathic renal stone formers (RSFs).The alterations in bone mineral content in RSFs have different explanations: prostaglandin-mediated bone resorption, subtle metabolic acidosis and 1–25 vitamin D disorders. Bone mineral content is worsened by insufficient dietary calcium leading to a negative calcium balance.

Albright F, Aub JC, Bauer W (1934) Hyperparathyroidism: a common and polymorphic condition as illustrated by 17 proven cases from one clinic. JAMA 102: 1276

Alhava EM, Juuti M, Karjalainen P (1976) Bone mineral density in patients with urolithiasis. Scand J Urol Nephrol 10: 154PubMed

Anderson J, Lee HA, Tomlinson RWS (1976) Some metabolic aspects of idiopathic hypercalciuria. Nephron 4: 129

Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J (1985) Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrol Metab 11: 19

Bataille P, Bouillon R, Fournier A, Renaud H, Gueris J, Idrissi A (1987) Increased plasma concentrations of total and free 1,25-(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. Contr Nephrol 58: 137

Bataille P, Achard JM, Fournier A, Boudail B, Westeel PF, Esper N, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Laval A, Jeantet MA, Bouillon R, Sebert JL (1991) Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39: 1193PubMed

Bataille P, Marie A, Ghazali A, Cohen Solal ME, Steiniche T, Brazier M, Gueris J, Sebert JL, Fournier A (1996) Histological and biochemical study of bone turnover in calcium stone formers (CSF) with fasting hypercalciuria and osteopenia. In: Pak CYC, Resnick MI, Preminger GM (ed) Urolithiasis 1996. Millet, Dallas, p 1

Bordier P, Ryckewart A, Gueris J (1977) On the pathogenesis of so-called hypercalciuria. Am J Med 63: 398CrossRefPubMed

Borghi L, Meschi T, Guerra A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A (1991) Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 146: 1334PubMed

10.

Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H (1980)The importance of circulating 1,25(OH)2D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N Engl J Med 302: 421

11.

Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311: 73PubMed

12.

Buck AC, Lote CJ, Sampson WF (1983) The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 129: 421PubMed

13.

Coe FL, Kavalach AG (1974) Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291: 1344PubMed

14.

Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, Gantt CL, Sherwood LM (1982) Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72: 25CrossRefPubMed

15.

Cormier C (1995) Markers of bone metabolism. Curr Opin Rheumatol 7: 243PubMed

16.

Dalen N, Hjern B (1974) Bone mineral content in patients with primary hyperparathyroidism without radiological evidences of skeletal changes. Acta Endocrinol 75: 297PubMed

17.

Dent CE, Hartland BV, Hicks J, Sykes ED (1961) Calcium intake with primary hyperparathyroidism. Lancet 2: 336CrossRefPubMed

18.

Diaz Perez de Madrid J, Munoz Torres M, Garcia de Vinuesa MJ, Mijan JL, Escobar Jimenez F, Zuluaga A (1989) Parathormone, cyclic AMP, 1,25 dihydroxyvitamin D and osteocalcin in hypercalciuric renal lithiasis. Arch Esp Urol 42: 129PubMed

19.

Filipponi P, Mannarelli C, Pacifici R, Grossi E, Moretti I, Tini S, Carloni C, Blass A, Morucci P, Hruska KA, Avioli LV (1988) Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 43: 61PubMed

20.

Forland M, Strandjord NM, Paloyan E, Cox A (1968) Bone density studies in primary hyperparathyroidism. Arch Intern Med 122: 236CrossRefPubMed

21.

Frost HM (1983) The skeletal intermediary organization: a review. Metab Bone Dis Rel Res 4: 281

22.

Fuss M, Gillet C, Simom J, Vandewalle J-C, Schoutens A, Bergmann P (1983) Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 9: 32PubMed

23.

Fuss M, Pepersack T, Bergman P, Hurard T, Simon J, Corvilain J (1990) Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol 65: 560PubMed

24.

Fuss M, Pepersack T, Van Geel J, Corvilain J, Vandewalle JC, Bergmann P, Simon J (1990) Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers. Calcif Tissue Int 46: 9PubMed

25.

Fuss M, Pepersack T, Corvilain J, Bergmann P, Simon J, Body JJ (1991) Calcitonin secretion in idiopathic renal stone formers. J Bone Miner Res 6: 35PubMed

26.

Ghazali A, Fuentes V, Deisaint C, Westeel A, Brazier M, Prin L, Fournier A (1997) Low bone mineral density and peripheral monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82: 32CrossRefPubMed

27.

Goldfarb S (1988) Dietary factors in the pathogenesis and prophylaxis of nephrolithiasis. Kidney Int 34: 544PubMed

28.

Hess B, Casez J-P, Takkinen R, Ackermann D, Jaeger P (1993) Relative hypoparathyroidism and calcitriol up-regulation in hypercalciuric calcium renal stone formers. Impact of nutrition. Am J Nephrol 13: 18PubMed

29.

Hisazumi H, Katsumi T (1970) A study of the mineral contents of the bone by x-rays in patients with urolithiasis. Jpn J Urol 61: 266

30.

Hosgkin DJ, Chamberlain MJ, Fremlin JH (1972) Changes in total body calcium content in primary hyperparathyroidism. Clin Sci 43: 627PubMed

31.

Jaeger P, Lippuner K, Casez J-P, Hess B, Ackermann D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9: 1525PubMed

32.

Jungers P, Houillier P, Liote F, De Groote D, Labrunie M, Daudon M, Descamps-Latscha B (1996) Imbalance between monocyte-derived cytokines and their specific inhibitors in idiopathic hypercalciuria. In: Pak CYC, Resnick MI, Preminger GM (eds) Urolithiasis 1996.. Millet, Dallas, p 68

33.

Kanis JA, Melton LJIII, Christiansen C, Johnson CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9: 1137PubMed

34.

Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1,25(OH)2D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59: 756PubMed

35.

Katayama Y, Umekawa T, Ishikawa Y, Kodama M, Takada M, Katoh Y, Kataoka K, Kohri K, Iguchi M, Kurita T (1990) Calcium urolithiasis and bone change. Nippon Hinyokika Gakkai Zasshi 81: 89PubMed

36.

Kuczera M, Wiecek A, Kokot F (1993) Estimation of selected markers of bone metabolism in patients with nephrolithiasis. Pol Arch Med Wewn 89:385PubMed

37.

Lauderdale DS, Thisted RA, Wen M, Favus MJ (2001) Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 16: 1893PubMed

38.

Lawoyin S, Sismilich S, Browne B, Pak CYC (1979) Bone mineral content in patients with calcium urolithiasis. Metabolism 28: 1250CrossRefPubMed

39.

Lemann JJr, Litzow JR, Lennon EJ (1966) The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis. J Clin Invest 45: 1608PubMed

40.

Liberman UA, Sperling O, Atsmon A (1969) Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest 47: 2580

41.

Lindergard B, Colleen S, Mansson W, Rademark C, Rogland B (1983) Calcium loading test and bone disease in patients with urolithiasis. Proc EDTA 20: 460

42.

Maierhofer WF, Gray RW, Cheung HS, Lemann J (1984) Dietary calcium and serum 1,25(OH)₂-vitamin D concentrations as determinants of calcium balance in healthy men. Kidney Int 26: 752PubMed

43.

Mallette LE, Bilezikian JP, Heath H, Auerbach GD (1974) Primary hyperparathyroidism: clinical and biochemical features. Medicine 53: 127PubMed

44.

Malluche HH, Tschope W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50: 654PubMed

45.

Malvasi L, Sartori I, Giannini S, Al Awady M, Musaio F, Varotto S, D’Angelo A (1988) Mineral metabolism and bone mineral content in calcium nephrolithiasis with and without hyperparathyroidism. Urol Res 16: 190

46.

Martin P, Bergmann P, Gillet C (1986) Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 146: 689CrossRefPubMed

47.

Maruyama Y, Hirata N, Yamada H, Sasaki K, Motomiya Y, Hirao Y, Okajima E (1993) A study on markers of bone metabolism in patients with non hypercalciuric calcium stone: measurement of gamma-carboxyglutamic acid and hydroxyproline. Nippon Hinyokika Gakkai Zasshi 84: 541PubMed

48.

Melton LJ III, Crowson CS, Khosla S, Wolson DM, O’Fallon WM (1998) Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 53: 459CrossRefPubMed

49.

Messa P, Mioni G, Montanaro D, Adorati M, Antonucci F, Favazza A, Messa A, Enzmann G, Paganin L, Nardini R (1987) About a primitive osseous origin of the so-called “renal hypercalciuria”. Contr Nephrol 58: 106

50.

Minisola S, Rosso R, Romagnoli E, Pacitti MT, Scarnecchia L, Carnevale V, Mazzuoli G (1993) Trabecular bone mineral density in primary hyperparathyroidism: relationship to clinical presentation and biomarkers of skeletal turnover. Bone Miner 20: 113PubMed

51.

Muldowney FP, Freaney R, Moloney MF (1982) Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 22: 292PubMed

52.

Netelenbos JC, Jongen MJM, Van der Vijgh WJF, Lips P, Van Ginkel FC (1985) Vitamin D status in urinary calcium stone formation. Arch Intern Med 145: 681CrossRefPubMed

53.

Nordin BEC, Peacock M, Wilkinson R (1972) Hypercalciuria and calcium stone disease. Clin Endocrinol Metab J 1: 169

54.

Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg (1993) Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism. Urol Res 21: 169CrossRefPubMed

55.

Pacifici R, Rothstein M, Rifas L, Lau KHW, Baylink DG, Avioli LV, Hruska K (1990) Increased monocyte interleukin-I activity and decreased vertebral bone density in patients with fasting hypercalciuria. J Clin Endocrinol Metab 71: 138PubMed

56.

Pak CYC, Kaplan R, Bone H, Towsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciuria. N Engl J Med 292: 497PubMed

57.

Pak CYC, Nicar MJ, Peterson R, Zerwekh JE, Snyder W (1981) Lack of unique pathophysiologic background for nephrolithiasis in primary hyperparathyroidism. J Clin Endocrinol Metab 53: 536PubMed

58.

Peacock M (1975) Renal stone disease in primary hyperparathyroidism and their relationship to the action of PTH on calcium absorption. In: Talmadge R (ed) Calcium regulating hormones. Excerpta Medica, Amsterdam, p 78

59.

Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7: 1383PubMed

60.

Pines KL, Mudge GH (1951) Renal tubular acidosis with osteomalacia. Am J Med 11: 302CrossRefPubMed

61.

Rao PN, Blacklock NJ (1983) A non-steroidal anti-inflammatory drug (flubiprofen) to control idiopathic hypercalciuria resistant to dietary manipulation. Br J Urol 55: 599PubMed

62.

Rao DS, Wilson RJ, Kleerkoper M et al. (1988) Lack of biochemical progression of continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for a biphasic course. J Clin Endocrinol Metab 67: 1294PubMed

63.

Rico H, Paramo P, Perez del Molino J, Nacarino L, Yague M (1988) Osteocalcin, parathormone and hypercalciuria. Eur Urol 15: 239PubMed

64.

Riggs BL, Wahner HW, Dunn WL, Mazess PB, Offord KP, Melton L (1981) Differential changes in bone mineral density of the appendicular and axial skeleton with ageing. J Clin Invest 67: 328PubMed

65.

Shen FH, Baylink DJ, Nielsen RL, Sherrard DJ, Ivey JL, Haussler MR (1977) Increased serum 1,25-dihydroxy vitamin D in idiopathic hypercalciuria. J Lab Clin Med 6: 955

66.

Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bliezikian JP (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89: 327CrossRefPubMed

67.

Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson (1998) Prevalence of renal stones in a population-based study of dietary calcium, oxalate, and medication exposures. Am J Epidemiol 147: 914PubMed

68.

Sperling O, Weinberger A, Oliver I, Liberman UA, De Vries A (1974) Hypouricemia, hypercalciuria and decreased bone density. A hereditary syndrome. Ann Intern Med 80: 482PubMed

69.

Steiniche T, Mosekilde L, Christensen MS, Melsen F (1989) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 4: 309

70.

Sutton RAL, Walker VR (1986) Bone resorption and hypercalciuria in calcium stone-formers. Metabolism 35: 485CrossRefPubMed

71.

Takeda M, Katayama Y, Go H, Wakatsuki S, Kawasaki T, Sato S, Odano I (1991) Bone mineral densitometry by dual photon absorptiometry in patients with urolithiasis: on the possibility of the differential diagnosis of idiopathic hypercalciuria. Nippon Hinoyokika Gakkai Zasshi 82: 1954

72.

Taylor AK, Lenken SA, Libanati C, Baylink DJ (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 20: 589PubMed

73.

Thomsen K, Gotfredsen A, Christiansen C (1986) Is postmenopausal bone loss an age-related phenomenon? Calcif Tissue Int 39: 123PubMed

74.

Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh A, Cohen N, Edelstein S, Liberman U (1987) Idiopathic hypercalciuria and hereditary hypophosphatemic rickets. N Engl J Med 316: 125PubMed

75.

Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E (1998) A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 159: 654CrossRefPubMed

76.

Trinchieri A, Zanetti G, Currò A, Lizzano R (2001) Effect of potential renal acid load of foods on calcium metabolism of renal calcium stone formers. Eur Urol 39 [Suppl 2]: 33

77.

Velentzas C, Oreopoulos DG, Meema S, Meema HE, Nutsuga T, Alison E, Katirtzoglou A, Crassweller P (1981) Dietary calcium restriction may be good for patients’ stones but not for their bones. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis clinical and basic research. Plenum Press, New York. p 847

78.

Weisenberg JR, Alonzo E, Bellorinfont E, Blasini AM, Rodriguez MA, Pazmartinez V, Martinis R (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49: 244PubMed

Titel: Bone mineral content in calcium renal stone formers
verfasst von: A. Trinchieri
Publikationsdatum: 01.08.2005
Verlag: Springer-Verlag
Erschienen in: Urolithiasis / Ausgabe 4/2005
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-005-0498-y

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bone mineral content in calcium renal stone formers

Abstract

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2005

Detection of endothelial nitric oxide synthase and NADPH-diaphorase in experimentally induced hyperoxaluric animals

Urothelial injury to the rabbit bladder caused by calcium dissolving agents including two new citrate solutions

Effects of trace metals on the inhibition of calcium oxalate crystallization

4th eULIS Symposium (11th European Symposium on Urolithiasis)

How painful are shockwave lithotripsy and endoscopic procedures performed at outpatient urology clinics?

Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie